Lytix Biopharma Company Contacts

Lytix Biopharma

http://www.lytixbiopharma.com/
Lytix Biopharma is a clinical-stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. Lead compound LTX-315 provides access to antigens by using the patient’s... Read More
Contacts

Country

Norway

City

Oslo

Headquarters

Oslo, NO

Profile

Founded

2003

Industry

Biotechnology

Size

11 - 50

Funding

Total Rounds

2

Last Round

Sun Oct 15 2023

Last Round Series

Grant

Last Round Raised

$ 1,308,793